Latest News and Updates
Men who have had surgery for early stage testicular cancer can avoid potentially harmful scans.
The results of the TRISST trial, presented today at GU ASCO 2021, offer less harmful ways of monitoring men who have had surgery for early stage testicular cancer, including reducing the number of scans or using MRI.
12 Feb
Tribute to Professor James Hakim
He will be greatly missed by his colleagues at the MRC CTU at UCL and around the world.
28 Jan
PediCAP recruits its first participant
The participant was recruited at the Makerere University Lung Institute in Uganda.
07 Dec
European Medicines Agency approves use of Dolutegravir 5 mg dispersible tablet for younger children living with HIV
These small tablets can now be used in combination with other medicines for treating children living with HIV who are aged at least four weeks and weigh at least 3kg.
19 Nov
Our Research Themes
Cancer
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Infections
Major international clinical trials answering questions of global public health significance
Methodology
Development of methods with direct impact on the design, conduct and analysis of studies
Our Latest Tweets
-
Men with early stage testicular cancer could benefit from fewer monitoring scans, allowing them to avoid unnecessary, potentially harmful radiation. Read more here: https://t.co/IHMNDOKmza @ASCO #GU21 @ICR_London @CR_UK #testicularcancer #seminoma
-
The results of the TRISST trial, presented today @ASCO #GU21, offer less harmful alternatives for monitoring men who have had surgery for early stage testicular cancer. Read more here: https://t.co/IHMNDOKmza @ICR_London @CR_UK #testicularcancer #seminoma
-
It is with great sadness that we learnt of the death of our friend and collaborator Professor James Hakim from #COVID19 complications. James will be greatly missed by his colleagues at the MRC CTU and around the world. https://t.co/1gyUcieUCs
